| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.80B | 25.45B | 23.25B | 18.71B | 15.27B | 12.56B |
| Gross Profit | 22.55B | 20.17B | 18.63B | 14.93B | 12.14B | 9.83B |
| EBITDA | 7.34B | 7.05B | 6.67B | 5.29B | 4.18B | 3.78B |
| Net Income | 3.97B | 3.87B | 3.80B | 2.93B | 2.26B | -1.96B |
Balance Sheet | ||||||
| Total Assets | 39.52B | 38.19B | 34.71B | 30.58B | 21.60B | 20.10B |
| Cash, Cash Equivalents and Short-Term Investments | 12.31B | 14.29B | 13.24B | 9.95B | 8.59B | 7.42B |
| Total Debt | 5.41B | 4.66B | 4.52B | 6.59B | 2.90B | 3.68B |
| Total Liabilities | 18.15B | 18.24B | 15.26B | 14.51B | 6.67B | 7.11B |
| Stockholders Equity | 21.40B | 19.98B | 19.45B | 16.07B | 14.93B | 12.99B |
Cash Flow | ||||||
| Free Cash Flow | 6.29B | 7.17B | 6.76B | 5.62B | 3.81B | 2.54B |
| Operating Cash Flow | 6.42B | 7.33B | 6.84B | 5.71B | 3.85B | 2.57B |
| Investing Cash Flow | -4.09B | -2.45B | -961.00M | -4.60B | -1.28B | -1.75B |
| Financing Cash Flow | -1.86B | -3.84B | -2.59B | 267.00M | -1.39B | -29.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥30.02B | 12.43 | ― | 0.38% | 18.02% | 46.43% | |
70 Outperform | ¥44.91B | 13.16 | ― | 1.54% | 10.84% | 5.13% | |
63 Neutral | ¥49.37B | 58.36 | ― | ― | 22.37% | 655.34% | |
61 Neutral | ¥20.29B | 26.23 | ― | ― | 28.90% | 29.06% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
51 Neutral | ¥66.38B | -34.22 | ― | ― | 31.11% | 96.33% |